Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Published:2016-05 Issue:5 Volume:22 Page:879-883
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Omer Aazim K.,Weisdorf Daniel J.,Lazaryan Aleksandr,Shanley Ryan,Blazar Bruce R.,MacMillan Margaret L.,Brunstein Claudio,Bejanyan Nelli,Arora Mukta

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report;Filipovich;Biol Blood Marrow Transplant,2005

2. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria;Jagasia;Biol Blood Marrow Transplant,2007

3. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD;Vigorito;Blood,2009

4. New classification of chronic GVHD: added clarity from the consensus diagnoses;Arora;Bone Marrow Transplant,2009

5. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report;Jagasia;Biol Blood Marrow Transplant,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease—an analysis from transplant centers across Europe;Frontiers in Transplantation;2024-03-18

2. Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD;Bone Marrow Transplantation;2024-02-21

3. Vedolizumab for second-line treatment of steroid-refractory gastrointestinal late acute graft-versus-host disease;Therapeutic Advances in Hematology;2024-01

4. Hepatic graft-versus-host disease: what we know, when to biopsy, and how to diagnose;Human Pathology;2023-11

5. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD;Blood Advances;2023-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3